• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. JUDE MEDICAL, BRASIL LTDA. (PAMPULHA) SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. JUDE MEDICAL, BRASIL LTDA. (PAMPULHA) SJM TRIFECTA VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number TF-19A
Device Problems Calcified (1077); Obstruction of Flow (2423)
Patient Problems Aortic Regurgitation (1716); Aortic Valve Stenosis (1717); Hemolytic Anemia (2279)
Event Date 11/16/2020
Event Type  Injury  
Manufacturer Narrative
The results/method and conclusion codes along with investigation results will be provided in a subsequent submission.
 
Event Description
On (b)(6) 2013, a 19mm sjm trifecta valve was implanted due to congenital aortic bicuspid valve.Additionally, the patient had mitral regurgitation and mitral valve annuloplasty and the ascending aortic replacement procedures done at the same time.In (b)(6) 2019, the patient developed anemia following a transverse colectomy.In (b)(6) 2019, aortic stenosis occurred with peak gradient as 64mmhg; the patient was asymptomatic and was monitored.However, the peak gradient increased to 77mmhg with a mean pg of 48mmhg.Therefore, on (b)(6) 2020, the patient underwent re-do aortic valve replacement (avr) and the trifecta valve was explanted due to hemolytic anemia.Upon explant, pannus formation on the lcc and ncc inflow sides and sclerosis due to calcification of the leaflets were confirmed.A new 17mm sjm regent heart valve was successfully implanted.The patient was reported to be in stable condition.
 
Manufacturer Narrative
Explant was reported due to hemolytic anemia.Also reported was stenosis, pannus and calcifications.The investigation found that all three leaflets contained calcifications.There was circumferential fibrous pannus ingrowth on the inflow surface which extended onto the base of all three leaflets.On the outflow surface, pannus extended onto leaflet 3.All three leaflets had fibrous thickening.Leaflet 3 contained a tear or excised tissue at the free edge.No inflammation was present.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.The calcifications and pannus noted could have contributed to the reported stenosis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SJM TRIFECTA VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ST. JUDE MEDICAL, BRASIL LTDA. (PAMPULHA)
rua professor jose vieira de mendonça 1301
engenho nogueira - belo horizonte - mg
belo horizonte 31310 -260
BR  31310-260
MDR Report Key11004340
MDR Text Key221477141
Report Number3001883144-2020-00118
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
PMA/PMN Number
P100029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 02/19/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/13/2014
Device Model NumberTF-19A
Device Lot Number3784821
Was Device Available for Evaluation? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 11/19/2020
Initial Date FDA Received12/14/2020
Supplement Dates Manufacturer Received02/17/2021
Supplement Dates FDA Received02/19/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age74 YR
Patient Weight47
-
-